60135-1-Ig

antibody from Proteintech Group

Targeting: CHGA

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

60135-1-Ig

Provider

Proteintech Group

Proper citation

Proteintech Cat#60135-1-Ig, RRID:AB_2260657

Product name

Chromogranin A antibody

Antibody type

Monoclonal

Description

Chromogranin A antibody (Cat. #60135-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, rat, pig, mouse and has been validated for the following applications: IF, IHC,ELISA.

Reactivity

Human, Mouse, Rat, Porcine

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

3H11C11

Vial size

20ul, 150ul

References

Submitted references

Organoid-based in vitro systems to model Cryptosporidium parvum infection in 2D and 3D.

Korwin-Mihavics BR, Dews EA, di Genova BM, Huston CD
bioRxiv : the preprint server for biology 2023 Sep 29;

---

Paneth cell-derived iNOS is required to maintain homeostasis in the intestinal stem cell niche.

Huang L, Xu Z, Lei X, Huang Y, Tu S, Xu L, Xia J, Liu D
Journal of translational medicine 2023 Nov 25;21(1):852

---

Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer.

Wang J, Li J, Yin L, Pu T, Wei J, Karthikeyan V, Lin TP, Gao AC, Wu BJ
Oncogene 2022 Sep;41(37):4307-4317

---

Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.

Bahl V, Lee May C, Perez A, Glaser B, Kaestner KH
Molecular metabolism 2021 Jul;49:101193

---

Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2.

Liu Q, Pang J, Wang LA, Huang Z, Xu J, Yang X, Xie Q, Huang Y, Tang T, Tong D, Liu G, Wang L, Zhang D, Ma Q, Xiao H, Lan W, Qin J, Jiang J
The Journal of pathology 2021 Jan;253(1):106-118

---

High throughput proteomic and metabolic profiling identified target correction of metabolic abnormalities as a novel therapeutic approach in head and neck paraganglioma.

Wang Z, Chen H, Xue L, He W, Shu W, Wu H, Wang Z
Translational oncology 2021 Aug;14(8):101146

---

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells.

Hor P, Ichida JK, Borok Z, Ryan AL
STAR protocols 2020 Sep 18;1(2):100068

---

N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.

He G, Li M, Fang L, Xu L, Huang X, Zheng L, Yang L, Luo W, Cai Y, Ma W, Liang C, Yin Y
Oncology reports 2020 Nov;44(5):2265-2274

---

Efficient Generation and Transcriptomic Profiling of Human iPSC-Derived Pulmonary Neuroendocrine Cells.

Hor P, Punj V, Calvert BA, Castaldi A, Miller AJ, Carraro G, Stripp BR, Brody SL, Spence JR, Ichida JK, Ryan Firth AL, Borok Z
iScience 2020 May 22;23(5):101083

---

Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction.

Yin L, Hu P, Shi X, Qian W, Zhau HE, Pandol SJ, Lewis MS, Chung LWK, Wang R
Scientific reports 2020 Jan 27;10(1):1216

---

The zinc transporter Zip14 (SLC39a14) affects Beta-cell Function: Proteomics, Gene expression, and Insulin secretion studies in INS-1E cells.

Maxel T, Smidt K, Petersen CC, Honoré B, Christensen AK, Jeppesen PB, Brock B, Rungby J, Palmfeldt J, Larsen A
Scientific reports 2019 Jun 13;9(1):8589